These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 11393392)

  • 1. Effectiveness of a second course of cyclophosphamide therapy in children with frequently relapsing nephrotic syndrome after cyclosporin A therapy.
    Kano K; Nishikura K; Hoshi M; Yamada Y; Arisaka O
    Clin Nephrol; 2001 May; 55(5):424-5. PubMed ID: 11393392
    [No Abstract]   [Full Text] [Related]  

  • 2. Single-center experience with cyclosporine for treatment of idiopathic minimal change nephrotic syndrome in children.
    Sabry A; El-Husseini A; El-Dahshan K; Sobh M
    Iran J Kidney Dis; 2009 Jul; 3(3):127-35. PubMed ID: 19617660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cyclosporin A versus cyclophosphamide in the treatment of nephrotic syndrome in children].
    Podracká L; Böör A; Sasinka M
    Cas Lek Cesk; 2008; 147(1):38-43. PubMed ID: 18323041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the efficacy of cyclosporine A treatment in idiopathic nephrotic syndrome in children].
    Wyszyńska T; Ksiazek J; Wieteska-Klimczak A; Gorzkowska-Paczwa M; Dorywalski T; Tysarowska A
    Pol Merkur Lekarski; 2001 Aug; 11(62):140-3. PubMed ID: 11757213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term steroid-immunosuppressive treatment of the childhood nephrotic syndrome.
    Pachioli R; Genova R
    Pediatrics; 1971 Apr; 47(4):731-6. PubMed ID: 4326172
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulse cyclophosphamide inadequately suppresses reoccurrence of minimal change nephrotic syndrome in corticoid-dependent children.
    Donia AF; Gazareen SH; Ahmed HA; Moustafa FE; Shoeib AA; Ismail AM; Khamis S; Sobh MA
    Nephrol Dial Transplant; 2003 Oct; 18(10):2054-8. PubMed ID: 13679480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
    Kyrieleis HA; Levtchenko EN; Wetzels JF
    Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
    du Buf-Vereijken PW; Wetzels JF
    Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Minimal change nephrotic syndrome].
    Hirayama K; Kobayashi M
    Nihon Jinzo Gakkai Shi; 2010; 52(7):882-7. PubMed ID: 21077335
    [No Abstract]   [Full Text] [Related]  

  • 10. Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome.
    Ueda N; Takahashi K; Akioka Y; Morooka M; Ogawa A; Tsuzuki K
    J Nephrol; 2009; 22(5):610-5. PubMed ID: 19809993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult minimal-change disease: clinical characteristics, treatment, and outcomes.
    Waldman M; Crew RJ; Valeri A; Busch J; Stokes B; Markowitz G; D'Agati V; Appel G
    Clin J Am Soc Nephrol; 2007 May; 2(3):445-53. PubMed ID: 17699450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of relapse in adults with minimal change nephrotic syndrome: myths and facts.
    Shigidi MM
    Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):10-7. PubMed ID: 21196608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of tacrolimus in steroid- and cyclophosphamide-resistant minimal change nephrotic syndrome.
    Tang S; Tang AW; Tam MK; Ho YW
    Am J Kidney Dis; 2003 Nov; 42(5):E13-5. PubMed ID: 14582073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can intravenous cyclophosphamide be used for steroid-dependent nephrotic syndrome?
    Bircan Z; Soran M; Kervancioglu M; Gonlusen G; Tuncer I
    Pediatr Nephrol; 1997 Feb; 11(1):127-8. PubMed ID: 9035189
    [No Abstract]   [Full Text] [Related]  

  • 15. [Minimal Change Glomerulonephritis].
    Stracke S; Helmchen U; Aymanns C; Kadlec N; Lindemann B; Hüttner S; Keller F
    Internist (Berl); 2003 Sep; 44(9):1090-7. PubMed ID: 14566462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of immunodepressive treatment in the nephrotic syndrome.
    Pachiolo R; Genova R
    Helv Paediatr Acta; 1970 Jan; 25(1):50-8. PubMed ID: 5438807
    [No Abstract]   [Full Text] [Related]  

  • 17. Minimal change nephropathy in a 7-year-old boy with Rosai-Dorfman disease.
    Sakallioglu O; Gok F; Kalman S; Atay AA; Kaya A; Duzova A; Gokcay E
    J Nephrol; 2006; 19(2):211-4. PubMed ID: 16736423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunosuppressive chemotherapy of lipoid nephrosis. I. Hematological study].
    Genova R; Tamborino G; Venturelli D
    Clin Pediatr (Bologna); 1969 Aug; 51(8):389-402. PubMed ID: 5384067
    [No Abstract]   [Full Text] [Related]  

  • 19. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
    Hoyer PF; Brodeh J
    J Am Soc Nephrol; 2006 Apr; 17(4):1151-7. PubMed ID: 16540560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus treatment for steroid- and cyclosporin-resistant minimal-change nephrotic syndrome.
    Schweda F; Liebl R; Riegger GA; Krämer BK
    Nephrol Dial Transplant; 1997 Nov; 12(11):2433-5. PubMed ID: 9394341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.